LBRX
LB Pharmaceuticals Inc Common Stock
NASDAQ: LBRX · HEALTHCARE · BIOTECHNOLOGY
$31.71
+3.66% today
Updated 2026-04-30
Market cap
$912.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.13
Dividend yield
—
52W range
$13 – $33
Volume
0.3M
LB Pharmaceuticals Inc Common Stock (LBRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-15.70%
ROA
-10.60%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-14.35M | — | — | — |
| 2023 | $0.00 | $-6.28M | — | — | — |
| 2024 | $0.00 | $-63.10M | — | — | — |
| 2025 | $0.00 | $-25.20M | — | — | — |